Intellectus Partners, LLC Intellia Therapeutics, Inc. Transaction History

Intellectus Partners, LLC

$441 Million
Q4 2024

A detailed history of Intellectus Partners, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 74,525 shares of NTLA stock, worth $686,375. This represents 0.2% of its overall portfolio holdings.

Number of Shares

74,525

Previous 58,825 26.69%

Holding current value

$686,375

Previous $1.21 Million 28.15%

% of portfolio

0.2%

Previous 0.32%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$11.41 - $21.09 $179,137 - $331,113	15,700 Added 26.69%	74,525 $868,000
Q3 2024 Nov 06, 2024	BUY	$19.72 - $27.36 $11,832 - $16,416	600 Added 1.03%	58,825 $1.21 Million
Q2 2024 Jul 18, 2024	BUY	$20.02 - $27.22 $24,524 - $33,344	1,225 Added 2.15%	58,225 $1.3 Million
Q1 2024 May 03, 2024	BUY	$23.82 - $32.8 $32,157 - $44,279	1,350 Added 2.43%	57,000 $1.57 Million
Q4 2023 Feb 05, 2024	BUY	$23.16 - $32.34 $113,484 - $158,466	4,900 Added 9.66%	55,650 $1.7 Million
Q3 2023 Oct 25, 2023	SELL	$31.62 - $45.78 $20,553 - $29,757	-650 Reduced 1.26%	50,750 $1.6 Million
Q2 2023 Jul 31, 2023	BUY	$34.58 - $46.03 $177,568 - $236,364	5,135 Added 11.1%	51,400 $2.1 Million
Q1 2023 May 04, 2023	BUY	$33.3 - $44.82 $19,980 - $26,892	600 Added 1.31%	46,265 $1.72 Million
Q4 2022 Feb 02, 2023	BUY	$33.21 - $62.69 $122,877 - $231,953	3,700 Added 8.82%	45,665 $1.59 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $67,939 - $90,342	-1,260 Reduced 2.91%	41,965 $2.35 Million
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $47,150 - $93,357	-1,225 Reduced 2.76%	43,225 $2.24 Million
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $179,180 - $365,894	-3,075 Reduced 6.47%	44,450 $3.23 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $345,103 - $473,883	-3,425 Reduced 6.72%	47,525 $5.62 Million
Q3 2021 Nov 16, 2021	BUY	$132.37 - $176.78 $304,451 - $406,594	2,300 Added 4.73%	50,950 $6.84 Million
Q2 2021 Aug 13, 2021	SELL	$60.88 - $161.91 $1.4 Million - $3.72 Million	-22,975 Reduced 32.08%	48,650 $7.88 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $265,563 - $476,976	5,700 Added 8.65%	71,625 $4.61 Million
Q4 2020 Feb 18, 2021	BUY	$18.83 - $63.53 $1.23 Million - $4.15 Million	65,275 Added 10042.31%	65,925 $3.59 Million
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $847,349 - $2.86 Million	-45,000 Reduced 98.58%	650 $3.59 Million
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $797,505 - $1.14 Million	45,650 New	45,650 $908,000

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

94.1M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $700M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Intellia Therapeutics, Inc. Transaction History